Home/Pipeline/Quadrivalent Influenza Virus Subunit Vaccine (Pediatric)

Quadrivalent Influenza Virus Subunit Vaccine (Pediatric)

Seasonal Influenza Prevention

Phase 3Awaiting NDA Approval

Key Facts

Indication

Seasonal Influenza Prevention

Phase

Phase 3

Status

Awaiting NDA Approval

Company

A Chinese vaccine developer advancing proprietary subunit and mRNA vaccines, with a lead quadrivalent influenza vaccine in late-stage trials.

Drug	Company	Phase	Status
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent	Hualan Biological Vaccine	Commercial	Marketed
Influenza mRNA Vaccine	Pfizer	Phase 3	Active
Cell Culture-Based Quadrivalent Influenza Vaccine	Hualan Biological Engineering	Phase III	Active
Quadrivalent Influenza Vaccine (QIV)	Hualan Biological Engineering	Marketed	Approved
Trivalent Influenza Vaccine (TIV)	Hualan Biological Engineering	Marketed	Approved
Quadrivalent Influenza Virus Subunit Vaccine (Adult)	AB & B Biotech	Phase 3	Awaiting NDA Approval
Trivalent Influenza Virus Subunit Vaccine	AB & B Biotech	Commercial	Market Tender Wins (e.g., Shanxi)